‘Furious’ Mounjaro users blast supermarket after prices hiked by £100 TODAY – as orders made weeks ago cancelled

BRITS have been left “furious” after Asda scrapped Mounjaro orders just days before a major price hike.

Shoppers who bought the fat jab in August for around £125 from the supermarket’s online doctor claim they were told their pens were “allocated”.

EPA

Asda customers are ‘furious’ after cheaper jab orders were scrapped[/caption]

Many were assured the price would be locked in, but this week their orders were scrapped, forcing them to pay £100 more for the same jab.

Taking to Reddit, some users called the last-minute cancellations “sketchy” and “diabolical”.

One customer wrote: “They kept pushing the review date back and telling me not to worry.

“Then out of nowhere they cancelled it. I was holding out hope because I’d ordered at the lower price.”

Someone else added: “If they’d cancelled a week ago I could have found somewhere else before the prices went up. I’m furious they left it until the last minute.”

Another said: “I don’t believe a doctor even looked at my consultation. They should never have accepted the order if they didn’t have stock.”

Others accused Asda of dropping them so they would have to pay the new higher price from September 1.

One user said: “I feel like they’re just cancelling orders so they can charge at the new price.”

Another added: “It’s diabolical – I’m so mad about it.”

In agreement, someone else said: “I know there’s only so much they can do because of Eli Lilly but this just feels so sketchy.”

Other providers are making the same move.

Online pharmacy Zava said all new requests will now be filled using stock bought at the updated supplier price.


Its revised pricing kicked in at 6pm on August 27 in line with similar changes across the industry.

Asda and Asda’s online doctor have been approached for comment.

Mounjaro, the ‘King Kong’ of weight loss jabs has been in short supply in the UK after manufacturer Eli Lilly imposed a nationwide freeze on new orders, as it prepares to raise prices by 170 per cent.

This could mean the cost of the highest dose going up from £122 to £330 per month.

Deliveries of the jabs to pharmacies were paused earlier this week, after patients attempted to stockpile the jabs before they become more expensive on September 1.

Pharmacists across the UK previously said they have been forced to ration orders and turn away patients, as stocks run thin.

Eli Lilly originally said the UK price of Mounjaro had to increase to be more in line with higher prices in Europe and the US.

US President Donald Trump had previously complained about the high cost of drugs in the US, compared to other countries, and threatened the pharmaceutical industry if they didn’t act.

Lilly has since apologised to UK patients who are “experiencing interruption”.

Emily Pegg, the manufacturer’s medical associate vice president said during an interview with ITV today that they are “sorry for patients who feel that they need to make decisions based on price”.

She added they are working with the NHS and private providers to maintain patient access. 

She also apologised to patients who are experiencing an interruption in their supply and encouraged patients to speak to healthcare professionals.

The drug works as an appetite suppressant by mimicking a hormone which makes people feel fuller

The weekly injection works by making you feel full so you eat less, and can help people lose 20 per cent of their body weight.

They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.

They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients’ sugar levels are too high.

Currently, there are thought to be around 1.5 million people on weight loss drugs in the UK with more than half of them on Mounjaro.

Estimates suggest nine in 10 pay for these drugs privately, buying from online services and high street pharmacies.

WHO IS ELIGIBLE FOR WEIGHT LOSS JABS ON THE NHS?

NHS eligibility for weight loss injections has expanded but still lags behind the number who could potentially benefit from taking them.

Wegovy, medical name semaglutide, is only available for weight loss through specialist weight management clinics.

Patients are typically expected to have tried other weight loss methods before getting a prescription.

They may be eligible if their body mass index (BMI) is higher than 30, or higher than 27 if they have a weight-related health condition such as high blood pressure.

Mounjaro, known as tirzepatide, is also available from GP practices but currently only to patients with a BMI of 40 or higher (or 37.5 if from a minority ethnic background) plus four weight-related health conditions.

The medicines are currently being rationed to the patients most in need.

NHS watchdog NICE estimates that more than three million Brits will ultimately be eligible.

The GLP-1 injections are prescribed separately by GPs for people with type 2 diabetes, and patients should discuss this with their doctor.

Total
0
Shares
Previous Post

Luke Rockhold left with horror gash in backstage brawl with rival Dillon Danis just hours before Misfits 22

Next Post

Joey Essex vs Numeiro: Start time, TV channel, live stream, full card for TOWIE star’s Misfits boxing debut

Related Posts